Skip to main content
Pidilite Industries Ltd. logo

Pidilite Industries Ltd. — Investor Relations & Filings

Ticker · PIDILITIND ISIN · INE318A01026 LEI · 335800APXGEBZ349GN74 BSE.NS Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2023-03-16 Regulatory Filings
Country IN India
Listing BSE.NS PIDILITIND

About Pidilite Industries Ltd.

https://www.pidilite.com

Pidilite Industries Ltd. specializes in the manufacture of adhesives, sealants, and construction chemicals. The company’s extensive portfolio includes well-known brands such as Fevicol, M-Seal, Fevikwik, and Dr. Fixit. Its operations are divided into consumer and bazaar products and industrial specialties, providing solutions for waterproofing, wood finishes, tile adhesives, and maintenance. The company serves a wide range of markets, including retail consumers, professional contractors, and industrial sectors such as packaging, footwear, and automotive. Beyond adhesives, the company offers art and craft materials and hobby colors. Pidilite is characterized by its strong brand equity, a robust distribution network, and a focus on research and development to deliver innovative chemical solutions for diverse applications.

Recent filings

Filing Released Lang Actions
Intimation as per Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges regarding the issue of duplicate share certificates to shareholders. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the loss of share certificates and issuance of duplicates. The content is about notifying the exchanges of this event and includes details of the duplicate certificates issued. There are no financial statements, earnings data, management discussion, or other report content. This is a regulatory compliance notification related to share certificates, not a financial report or management announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-16 English
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events. The content is purely an announcement of scheduled meetings with investors and does not contain any financial data, report, or detailed presentation. The document length is short (1972 characters), and it is an announcement rather than a report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-03-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events. The content is a notification of scheduled meetings rather than a report or financial data. The document length is short (1972 characters), and it does not contain financial statements, management discussion, or any detailed report. It is an announcement of investor meetings, which aligns with the category of Investor Presentation (IP) or possibly Regulatory Filings (RNS). However, since it is specifically about scheduling investor meetings and not the presentation itself, it is best classified as a Regulatory Filing (RNS) as a general disclosure under SEBI regulations.
2023-03-10 English
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events. The content is an announcement of upcoming investor meetings, not a financial report, earnings release, or detailed presentation. The document length is short (1887 characters), and it does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-03-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events or information. The content is an announcement of upcoming meetings rather than a report or transcript of the meetings themselves. The document length is short (1887 characters), and it does not contain financial data, management discussion, or detailed presentations. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit into more specific categories like Investor Presentation or Call Transcript.
2023-03-08 English
Updates
Capital/Financing Update Classification · 100% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding an investment made by the company's wholly owned subsidiary in another company. It mentions Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about a capital investment transaction, specifically a primary purchase of shares increasing the stake in another company. There is no financial report, earnings data, or management discussion. The document is an update on financing activity, i.e., investment and capital structure change. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and does not indicate it is an announcement of a report publication or a regulatory filing of a different nature.
2023-03-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.